The average trading volume of PLRZ on June 27, 2025 was 2.71M shares.
PLRZ) stock’s latest price update
Polyrizon Ltd (NASDAQ: PLRZ)’s stock price has soared by 3.26 in relation to previous closing price of 0.7. Nevertheless, the company has seen a loss of -0.14% in its stock price over the last five trading days. globenewswire.com reported 2025-06-12 that Ra’anana, Israel, June 12, 2025 (GLOBE NEWSWIRE) — Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a biotechnology company developing intranasal drug delivery systems, today announced encouraging preclinical results from a recent study evaluating its proprietary hydrogel-based Trap & Target (T&T) platform.
PLRZ’s Market Performance
Polyrizon Ltd (PLRZ) has experienced a -0.14% fall in stock performance for the past week, with a -29.32% drop in the past month, and a -99.42% drop in the past quarter. The volatility ratio for the week is 8.39%, and the volatility levels for the past 30 days are at 21.21% for PLRZ. The simple moving average for the past 20 days is -9.24% for PLRZ’s stock, with a -99.64% simple moving average for the past 200 days.
PLRZ Trading at -98.31% from the 50-Day Moving Average
After a stumble in the market that brought PLRZ to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.94% of loss for the given period.
Stock Fundamentals for PLRZ
The total capital return value is set at -0.25. Equity return is now at value -57.83, with -50.61 for asset returns.
Currently, EBITDA for the company is -1.42 million with net debt to EBITDA at 2.16. The liquidity ratio also appears to be rather interesting for investors as it stands at 10.16.
Conclusion
In conclusion, Polyrizon Ltd (PLRZ) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
